Scholars@Duke
Andrew M. Peseski

Andrew M. Peseski

Assistant Professor of Medicine
Medicine, Hematology

Scholarly Works - Conferences

Cytoreductive therapy reduces recurrent thrombosis in patients with myeloproliferative neoplasm-associated splanchnic vein thrombosis: A global abdominal/splanchnic thrombosis retrospective observational study (GASTRO-MPN) study of 757 patients

Conference Blood · November 3, 2025 AbstractBackground Patients with myeloproliferative neoplasms (MPNs) are at risk of splanchnic vein thrombosis (SVT). Prior studies failed ... Full text Cite

Comparative Analysis of Perioperative Anticoagulation Management Guidelines across U.S. Institutions

Conference Blood · November 5, 2024 IntroductionGuidelines for perioperative management of oral anticoagulants exist to balance the risk of bleeding against thromboembolism. We evaluated ... Full text Cite

Variation in Anticoagulant Hemorrhage Management Guidelines for Factor-Xa Inhibitors: A Survey and Analysis of U.S. Academic Institutions

Conference Blood · November 5, 2024 BackgroundAndexanet alfa (AA) is a decoy protein that acts by binding and sequestering factor-Xa inhibitors. Approved by the United States (US) Food an ... Full text Cite

Treatment Complications of Venous Thromboembolism in Patients with Central Nervous System Tumors

Conference Blood · November 2, 2023 Introduction: In the last decade, landmark studies have been conducted in patients with cancer-associated venous thromboembolism (CA-VTE), helping to guide treatment decisions of anticoagulant therapy. Although these tr ... Full text Cite